Fig. 4From: The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC)Validation of a risk-prediction model in test dataset. A Risk score in the TCGA test set, patient survival, and expression of 14 DEGs in the test set. B The risk scores of NSCLC in TCGA database. C Kaplan–Meier curves of patients in 2 ferroptosis-associated clusters for overall survival. D The distribution of survival status and risk scores in NSCLC patients. E ROC curve of the risk score modelBack to article page